News for Corvus Pharmaceuticals Inc (C17.MU)

BURLINGAME, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today ...

(RTTNews) - Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S ...

Are Analysts Right About These Penny Stocks To Buy? Who’s ready for another busy week with penny stocks? I know after a short week last week – and a volati...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Biotech stocks and secondary and i...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Biotech stocks and secondary and initial ...

A historic economic comeback is sending some of the world’s biggest investors bargain hunting in the unloved energy sector. Warren Buffett’s Berkshire...

BURLINGAME, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today ...

Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading lower Friday after the company priced its 8.571 million share common stock offering at $3.50 per ...

TMSR Holding Co Ltd operates in two business divisions that are Shengrong, which engages in the production and sales of solid waste recycling and comprehensive ...